In addition, genes such as CEBPD, FUT4, LILRB1 and MVP play a role in the cure, the treatment, and clinical drug resistance of AML [22], providing theoretical directions for the treatment of CML and finding new therapeutic targets in future. The gene discussed is LILRB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.